RxDoctor Payments Data

Reyna Chavarri

Physician Assistant · Edinburg, TXNPI 1457005456

Payments from drug & device makers

$6,212in general payments, 2019–2025

Across 220 payments — averaging $28.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • Amgen$757
  • Aurinia Pharma U.S., Inc.$522
  • ANI Pharmaceuticals, Inc.$466
  • AstraZeneca$466
  • UCB, Inc.$371
  • plus $2K from 21 others

What the payments were for

  • Food & beverage$5,84594%
  • Education$3676%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,212 in reported general payments places this provider in the 90th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel SureclickEtanercept60$446,878
Humira(Cf) PenAdalimumab51$340,751
Enbrel MiniEtanercept35$281,915
RinvoqUpadacitinib38$259,000
Cosentyx Unoready PenSecukinumab26$242,292
Xeljanz XrTofacitinib Citrate20$112,155
Taltz AutoinjectorIxekizumab16$106,959
Cyltezo(Cf)Adalimumab-Adbm13$84,610
Humira(Cf)Adalimumab12$82,617
Orencia ClickjectAbatacept15$80,790
Cimzia (2 Pack)Certolizumab Pegol13$71,527
OtezlaApremilast13$62,423
Teriparatide12$21,159
Hydroxychloroquine Sulfate352$16,187
Leflunomide159$11,706

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq, Humira(Cf)$366$341,61850 claims
Boehringer IngelheimCyltezo(Cf)$29$84,61013 claims
UCB, Inc.Cimzia (2 Pack)$371$71,52713 claims
AmgenOtezla$757$62,42313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Edinburg

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →